Interested in the latest perspectives on lung cancer screening?
Register now for this upcoming webinar for a summary and discussion of the IARC Perspective on Lung Cancer Screening, published in the New England Journal of Medicine.
📅 Date: 23 November
Out now: our October selection of publications on EuroQol instruments 📚
Features 10 new papers covering EQ-TIPS, cross-cultural relevance of EQ-5D, carer outcomes, bolt-ons, population norms, and more.
Check them out: bit.ly/4jk06RS#HRQoL#HealthEconomics#PROMs
Preparing a grant application?
Can CQUEST help with any PROMs component?
Drop in for a chat today, and we can provide advice on the spot!
utsmeet.zoom.us/j/8335777658…
📢 Applications are now open for ANZGOG's 2026 Fund for New Research Grants.
The next breakthrough in gynaecological cancer treatment, prevention, or care could start with a research question waiting to be answered.
ANZGOG is pleased to open applications for the 2026 Fund for New Research Grant Program, supporting researchers to explore innovative ideas and generate the evidence needed to progress larger studies and future clinical trials.
Thanks to the generosity of ANZGOG donors, funding is available across four priority research areas:
🔹 Endometrial cancer focused surgical study – up to $55,000
🔹 Leiomyosarcoma focused project – $65,000
🔹 Endometrial cancer focused project – up to $100,000
🔹 Clinical or pre-clinical ovarian carcinosarcoma project – up to $50,000
These grants are designed to support early-stage research, helping investigators test promising concepts and build the foundations for future discoveries that improve outcomes for people affected by gynaecological cancers.
Learn more and apply: anzgog.org.au/research/fund-…#GynaecologicalCancer#CancerResearch#ResearchFunding
Applications for the First Nations Cancer Scholarship close on 11/09.
Indigenous students engaged in full-time postgraduate studies or research within a cancer-related field covering health, research, or policy are eligible. Learn more: bit.ly/4en2NzR@AuroraEducation
Cancer Australia is calling for applications for the First Nations Cancer Scholarship - a dedicated funding for Aboriginal & Torres Strait Islander students, health professionals and researchers in the field of cancer.
Learn more: bit.ly/4en2NzR@AuroraEducation
🔍 New @EORTC#QualityofLife publication.
The new EORTC QLQ‑VU34 was developed to assess quality of life in women with vulva cancer.
Cross-cultural testing in 9 countries showed high relevance, acceptability & comprehensiveness.
🔗 eortc.org/publications/#GivingVoice2Patients
Setting the record straight on EQ-5D nomenclature 📣
EQ-5D is not an abbreviation. It's the correct term when referencing all four versions of the instrument. This means their names should not be spelt out as this is inaccurate.
Learn more 👉 bit.ly/3PQbclO#PROMs
Are you looking for an opportunity to build your CV while further advancing the #HRQL field? Apply to serve as an Associate Editor for the Journal of Patient-Reported Outcomes (JPRO) or Quality of Life Research (QLR)! Learn more at buff.ly/PUYxQw3
We're proud to share our 2025 Annual Research Report, which showcases a year of significant trial milestones, forging international partnerships, new grant funding and deeper consumer engagement to drive meaningful research to improve cancer outcomes.
ap1.hubs.ly/y0YF8b0
Have a melanoma or skin cancer research idea? 🔬
Submit your concept to be developed at our MASC Trials workshop & receive expert feedback.
📅 25 June, 9am – 1pm
👉 Register ow.ly/Nzta50Z6uE5
📧 Submit: grants@masc.org.au
#MelanomaResearch#SkinCancer#ClinicalTrials
Reminder: one month remains to submit to QLR's special issue, "Quality of life in people with mental disorders – beyond global scores." Learn more at buff.ly/WEOrYmH
Early bird registrations for the 2026 TOGA ASM extended until 8 June!
Don’t miss your opportunity to attend one of Australia’s leading thoracic oncology meetings at discounted rates.
✔ Outstanding scientific program
✔ International and local experts
June is Uterine Cancer Awareness Month, and the picture across Australia and Aotearoa New Zealand cannot be ignored.
Uterine cancers are the most common and fastest rising gynaecological cancers in Australia and Aotearoa New Zealand. And most women have never heard of it.
Around 12 women across both countries will hear those words today. More than two will lose their lives.
Yet 94% of women report they were unaware of uterine cancer. It is unknown, underfunded, and unsupported. Uterine cancers are the poorest funded cancer in terms of research funding, both in absolute terms and in terms of disease burden.
That has to change. Our State of the Nation report sets out what we know and what must be done. Read it here: anzgog.org.au/state-of-the-n…@CancerAustralia#UCAM#UterineCancer#EndometrialCancer#AdvancingResearchSavingLives